INDUCTION OF HIGH-AFFINITY PAF RECEPTOR EXPRESSION DURING T-CELL ACTIVATION

被引:36
|
作者
CALABRESSE, C
NGUER, MC
PELLEGRINI, O
BENVENISTE, J
RICHARD, Y
THOMAS, Y
机构
[1] INSERM,U200,32 RUE CARNETS,F-92140 CLAMART,FRANCE
[2] UNIV PARIS SUD,U131,CLAMART,FRANCE
关键词
D O I
10.1002/eji.1830220604
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activated human T cells via the CD2 or the CD3 pathways exhibited a higher capacity than resting T lymphocytes to incorporate and metabolize [H-3] paf-acether (paf) at 37-degrees-C. Resting T lymphocytes lacked specific binding capacity for paf, yet high-affinity paf receptors (paf-R) were induced on CD3- or CD2-dependent activation. This up-regulation in the number of paf-R became apparent by day 1 of culture, reached a maximum of about 25 000 sites cell by days 4 to 6 and subsequently declined. Interestingly, human recombinant interleukin-2 in. a dose-dependent manner prevented the decrease of high-affinity paf-R expression on T cells. By contrast, the receptor affinity was constant throughout the culture period. Thus, paf-R at different stages of T cell activation were indistinguishable with respect to receptor-ligand interaction, and differed only in their number. Together, these data demonstrate that after activation human T cells develop membrane high-affinity paf-binding sites. They also suggest for the first time that expression of the paf-R are coupled to T cell activation and/or differentiation.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 50 条
  • [41] THE RECEPTOR WITH HIGH-AFFINITY FOR IGE
    METZGER, H
    IMMUNOLOGICAL REVIEWS, 1992, 125 : 37 - 48
  • [42] THE RECEPTOR WITH HIGH-AFFINITY FOR IGE
    METZGER, H
    KINET, JP
    BLANK, U
    MILLER, L
    RA, C
    CIBA FOUNDATION SYMPOSIA, 1989, 147 : 93 - 113
  • [43] A high affinity T cell receptor?
    Alberti, S
    IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (03): : 292 - 297
  • [44] INDUCTION OF T-CELL ACTIVATION BY MONOCLONAL-ANTIBODIES SPECIFIC FOR THE TRANSFERRIN RECEPTOR
    CANO, E
    PIZARRO, A
    REDONDO, JM
    SANCHEZMADRID, F
    BERNABEU, C
    FRESNO, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (04) : 765 - 770
  • [45] T-CELL RECEPTOR AND T-CELL ACTIVATION PROFILES IN GVHD IN MAN
    QUARATINO, S
    KAHAN, M
    CAPPONI, D
    POLCHI, P
    LONDEI, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 382 - 382
  • [46] DECREASED EXPRESSION OF HOMING RECEPTOR AFTER T-CELL ACTIVATION IS REVERSIBLE
    JUNG, TM
    DAILEY, MO
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 758 - 758
  • [47] Generation of ImmTACTM molecules: Engineering high-affinity soluble T-cell receptors for the treatment of cancer
    Bombik, Izabela
    Bortoluzzi, Alessio
    Mai, Nicole
    Preston, Andrew
    Vuidepot, Annelise
    Jakobsen, Bent K.
    Liddy, Nathaniel
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [48] HIGH-AFFINITY T-CELL ROSETTES - EFFECTS OF CLINICAL MANIPULATIONS AND POTENTIAL PROGNOSTIC-SIGNIFICANCE
    WEESE, JL
    WEST, WH
    HERBERMAN, RB
    PAYNE, SM
    SIWARSKI, JW
    TURCOTTE, JG
    JOURNAL OF SURGICAL ONCOLOGY, 1980, 13 (02) : 145 - 153
  • [49] STRUCTURE OF THE HIGH-AFFINITY MAST-CELL RECEPTOR FOR IGE
    METZGER, H
    GOETZE, A
    KANELLOPOULOS, J
    HOLOWKA, D
    FEWTRELL, C
    FEDERATION PROCEEDINGS, 1982, 41 (01) : 8 - 11
  • [50] Optimal T-cell receptor affinity for inducing autoimmunity
    Koehli, Sabrina
    Naeher, Dieter
    Galati-Fournier, Virginie
    Zehn, Dietmar
    Palmer, Ed
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (48) : 17248 - 17253